News
Both sides of the aisle -- and even the former Eli Lilly exec himself -- expressed concerns over the ballooning drug prices and stressed the need to make pharmaceuticals more affordable.
As the popularity, and profitability, of urine tests has expanded, so has the potential for fraud and malpractice.
Layoffs for workers in Delaware follow hundreds in Phoenix earlier this month after loss of TriCare contract.
So far this in this year, 2.78 million consumers have signed up for health plans.
Optum Ventures will combine the funding, analytics capabilities and its vast network to make bold bets on emerging digital health companies.
Despite growth of these plans, price shopping, cost discussions with doctors are rarely happening, researchers find.
Insurers, providers, pharma urge CMS to reconsider allowing states to set essential health benefit benchmarks.
Going beyond the CapEx vs. OpEx debate, experts say the time has come for finance teams to decide what to move to the cloud and what to keep on-site.
The 30-year veteran most recently served as the executive vice president and CFO of JDA Software Group, a privately-held supply chain provider of software and SaaS solutions.
But study suggests the U.S. as a whole is not doing particularly well when it comes to pulling back on outdated procedures.